EU-LIFE charter of independent life science research institutes
Language English Country Great Britain, England Media print-electronic
Document type Editorial
Grant support
Each director and administrator was supported by the respective organization
- MeSH
- Academies and Institutes MeSH
- Biological Science Disciplines * MeSH
- Biomedical Research * MeSH
- Publication type
- Editorial MeSH
The diverse range of organizations contributing to the global research ecosystem is believed to enhance the overall quality and resilience of its output. Mid-sized autonomous research institutes, distinct from universities, play a crucial role in this landscape. They often lead the way in new research fields and experimental methods, including those in social and organizational domains, which are vital for driving innovation. The EU-LIFE alliance was established with the goal of fostering excellence by developing and disseminating best practices among European biomedical research institutes. As directors of the 15 EU-LIFE institutes, we have spent a decade comparing and refining our processes. Now, we are eager to share the insights we've gained. To this end, we have crafted this Charter, outlining 10 principles we deem essential for research institutes to flourish and achieve ground-breaking discoveries. These principles, detailed in the Charter, encompass excellence, independence, training, internationality and inclusivity, mission focus, technological advancement, administrative innovation, cooperation, societal impact, and public engagement. Our aim is to inspire the establishment of new institutes that adhere to these principles and to raise awareness about their significance. We are convinced that they should be viewed a crucial component of any national and international innovation strategies.
CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences Vienna Austria
Center for Genomic Regulation Barcelona Spain
Center for Physiology and Pharmacology Medical University of Vienna Austria
Central European Institute of Technology Brno Czech Republic
European Institute of Oncology Milan Italy
Friedrich Miescher Institute for Biomedical Research Basel Switzerland
Institute for Molecular Medicine Helsinki Finland
Institute of Molecular Biology and Biotechnology Heraklion Greece
Instituto Gulbenkian de Ciência Oeiras Portugal
International Institute of Molecular and Cell biology Warsaw Poland
Max Delbrück Center for Molecular Medicine in the Helmholtz Association Berlin Germany
The Babraham Institute Cambridge UK
The Netherlands Cancer Institute Amsterdam The Netherlands
The University of Copenhagen Biotech Research and Innovation Centre Denmark
See more in PubMed
Bradke F, Maartens A and Teichmann SA (2023) Key attributes of successful research institutes. PLoS Biol 21, e3002267.
Hunter P (2013) EU‐LIFE revives funding debate. A group of mid‐level LIFE science research institutes is reopening the debate on how to fund research at the EU level calling for a stronger emphasis on excellence. EMBO Rep 14, 1047–1049.
Nowotny H (2017) ERC‐the next 10 years. Science 355, 997.
Lamond AI, Dikic I, Nussenzweig A, Müller CW, Thornton JM and Yaffe MB (2023) The mission to ensure continued funding for excellent basic research. EMBO Rep 24, e57498.
Brenner S (2002) Life sentences: detective rummage investigates. Genome Biol 3, comment1013.1–comment1013.2.
Bentires‐Alj M, Rajan A, van Harten W, van Luenen HG, Kubicek S, Andersen JB et al. (2015) Stimulating translational research: several European life science institutions put their heads together. Trends Mol Med 21, 525–527.
Garrison H, Agostinho M, Alvarez L, Bekaert S, Bengtsson L, Broglio E, Couso D, Araújo Gomes R, Ingram Z, Martinez E et al. (2021) Involving society in science: reflections on meaningful and impactful stakeholder engagement in fundamental research. EMBO Rep 22, e54000.
